Literature DB >> 15095778

How important is the size of a reprint order?

Sally Hopewell1, Mike Clarke.   

Abstract

OBJECTIVES: This study aims to assess the impact of articles with very high reprint orders ("high-reprint articles") by measuring their citation in the subsequent literature as compared with a control group of articles.
METHODS: The twenty-one articles (published in the Lancet in 1998) with reprint orders of over 10,000 were matched with a control set of twenty-one articles with smaller reprint orders. The Science Citation Index was used to obtain the number of citations for each of the forty-two articles.
RESULTS: The twenty-one high-reprint articles were cited 2,548 times; the mean number of citations was 121 (range, 3 to 499 citations per article). Five of the twenty-one high-reprint articles had more than 200 citations, but seven (33%) were cited twenty-five times or fewer. The twenty-one control articles were cited 986 times; the mean number of citations was forty-seven (range, 1 to 165). Fifteen (71%) of the twenty-one control articles were cited twenty-five times or fewer. Thirteen of the high-reprint articles were reports of randomized trials with a mean of 163 citations. In the control articles, six were reports of randomized trials with a mean of eighty-eight citations.
CONCLUSIONS: Articles with a high-reprint order were cited more frequently than other articles. However, some high-reprint articles were cited infrequently. If the size of a reprint order is related to the importance of an article, those articles with very high reprint orders may, therefore, be perceived as more important. Further research is needed to explore other aspects of the relative importance and impact of high-reprint articles.

Mesh:

Year:  2003        PMID: 15095778     DOI: 10.1017/s0266462303000680

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  6 in total

1.  Number of citations 1 year after publication of trial results and their relation to medicines regulatory approval.

Authors:  Rafael Dal-Ré
Journal:  Br J Clin Pharmacol       Date:  2016-01-14       Impact factor: 4.335

2.  Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study.

Authors:  Andreas Lundh; Marija Barbateskovic; Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  PLoS Med       Date:  2010-10-26       Impact factor: 11.069

3.  High reprint orders in medical journals and pharmaceutical industry funding: case-control study.

Authors:  Adam E Handel; Sunil V Patel; Julia Pakpoor; George C Ebers; Ben Goldacre; Sreeram V Ramagopalan
Journal:  BMJ       Date:  2012-06-28

4.  Role of editorial and peer review processes in publication bias: analysis of drug trials submitted to eight medical journals.

Authors:  Marlies van Lent; John Overbeke; Henk Jan Out
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

5.  Identifying the Factors Affecting Papers' Citability in the Field of Medicine: an Evidence-based Approach Using 200 Highly and Lowly-cited Papers.

Authors:  Mousa Yaminfirooz; Farzaneh Raeesi Ardali
Journal:  Acta Inform Med       Date:  2018

6.  Publishing clinical trial results: the future beckons.

Authors:  Elizabeth Wager
Journal:  PLoS Clin Trials       Date:  2006-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.